Heron Therapeutics Inc stock is traded at $0.3706, with a volume of 137,301,170. It is up +26.48% in the last 24 hours and down -8.74% over the past month. Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Previous Close:
$0.293
Open:
$0.3676
24h Volume:
137,301,170
Relative Volume:
9.32
Market Cap:
$70.36M
Revenue:
$150.71M
Net Income/Loss:
-$30.94M
P/E Ratio:
-
EPS:
-$0.1767
Net Cash Flow:
-$20.86M
1W Performance:
+25.58%
1M Performance:
-8.74%
6M Performance:
-69.37%
1Y Performance:
-66.31%
1-Day Range:
$0.35$0.42
1-Week Range:
$0.2662$0.42
52-Week Range:
$0.261$1.58
Heron Therapeutics Inc Stock (HRTX) Company Profile
Name
Heron Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
(858) 251-4400Address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS